Publication Name	World Journal of Gastroenterology
Manuscript ID	8347
Country	United States

Received	2013-12-26 13:47
Peer-Review Started	2013-12-26 15:02
To Make the First Decision
Return for Revision
Revised	2014-02-11 01:53
Second Decision	2014-05-14 09:19
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-05-14 09:36
Articles in Press	2014-05-23 09:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-07-02 15:25
Publish the Manuscript Online	2014-07-21 17:17

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pathology
Manuscript Type	Topic Highlights
Article Title	Role of liver biopsy in nonalcoholic fatty liver disease
Manuscript Source	Invited Manuscript
All Author List	ILKe Nalbantoglu and Elizabeth M Brunt
Funding Agency and Grant Number
Corresponding Author	ILKe Nalbantoglu, MD, Department of Pathology and Immunology, Washington University School of Medicine, Campus Box 8118, 660 S Euclid Ave, Saint Louis, MO 63110, United States. inalbantoglu@path.wustl.edu
Key Words	Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Liver biopsy; Histopathology; Grading and staging
Core Tip	Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease; no clinical or serologic tests have yet replaced liver biopsy for definitive diagnosis. The histologic spectrum includes steatosis, steatohepatitis, and cirrhosis with or without active steatohepatitis. Hepatocellular carcinoma may occur in cirrhosis, or prior to cirrhosis. Liver biopsy provides vital data for patient care, clinical trials, and for ongoing research into nuances of the disease process. The histologic spectrum of NAFLD, features with co-existent diseases, differential diagnoses, grading and staging methods and the role of liver biopsy, as well as a brief description of non-invasive alternatives, are discussed.
Publish Date	2014-07-21 17:17
Citation	Nalbantoglu I, Brunt EM. Role of liver biopsy in nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(27): 9026-9037
URL	http://www.wjgnet.com/1007-9327/full/v20/i27/9026.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i27.9026

Full Article (PDF)	WJG-20-9026.pdf
Full Article (Word)	WJG-20-9026.doc
Manuscript File	8347-Review.docx
Answering Reviewers	8347-Answering reviewers.pdf
Copyright License Agreement	8347-Copyright assignment.pdf
Peer-review Report	8347-Peer reviews.pdf
Scientific Editor Work List	8347-Scientific editor work list.pdf